# CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes

> **NCT03350828** · — · ACTIVE_NOT_RECRUITING · sponsor: **Nicole Hamblett** · enrollment: 5000 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03350828
- **Lead sponsor:** Nicole Hamblett
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-01-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 5000 (ESTIMATED)
- **Last updated:** 2025-10-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03350828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03350828, "CHaractErizing CFTR Modulated Changes in Sweat Chloride and Their Association With Clinical Outcomes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03350828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*